Timothy G. Youngquist 2020 Irrevocable Trust Reports 8.3% Stake in Coherus Oncology, Inc.

Timothy G. Youngquist 2020 Irrevocable Trust has filed a Schedule 13G/A (Amendment No. 2) regarding its holdings in Coherus Oncology, Inc. (CHRS). As of the event date on March 31, 2026, the Trust reported beneficial ownership of 12,750,800 shares of common stock, representing an 8.3% stake in the company. This filing serves as an increase from a previously reported 0.0% position, though the amendment specifically notes it was filed to correct information from a prior amendment. The reported holdings include 460,000 shares underlying call options exercisable within 60 days. The Trust, based in Fort Myers, Florida, maintains sole voting and dispositive power over the entire share count. The calculation of the ownership percentage is based on 154,217,609 shares outstanding as of April 16, 2026. The filing confirms that the securities were acquired in the ordinary course of business and not for the purpose of influencing or changing the control of the issuer.